摘要
目的:研究DLC-1基因甲基化检测与肝细胞癌(hepatocellular carcinoma,HCC)复发转移的关系.方法:73例HCC标本依据临床以及病理学特征被分为高侵袭组和低侵袭组;采用甲基化特异性PCR对不同侵袭组HCC之间DLC-1基因甲基化表达进行分析.结果:DLC-1甲基化表达率高侵袭组明显高于低侵袭组,二者之间有明显差异(χ2=4.3567P<0.05).DLC-1甲基化阳性与阴性患者之间AFP、HBV双阳性率有明显差异(χ2=4.4224P<0.05);TNM分期越后DLC-1甲基化程度越高(χ2=10.8478,P<0.05);短期随访发现DLC-1甲基化的HCC患者中位生存期低于非甲基化患者(9.45movs36mo,P<0.05).结论:DLC-1基因甲基化可作为HCC复发转移监测指标,并可作为靶向治疗HCC复发转移的新靶点.
AIM: To investigate the relationship between the methylation status of DLC-1 gene and metastasis of hepatocellular carcinoma (HCC). METHODS: Seventy-three surgical specimens of human HCC were divided into high- and low-invasion groups according to their clinicopathological features. The methylation status of DLC-1 gene was detected in both groups by methylation-specific polymerase chain reaction (MSP). RESULTS: The methylation level of DLC-1 gene in HCC specimens with high invasion was significantly higher than that in specimens with low invasion (χ^2 = 4.3567, P 〈 0. 05). The doublepositive rate of alpha-fetoprotein (AFP) andhepatitis B virus (HBV) was significantly different between methylation-positive and -negative specimens (χ^2 = 4.4224, P 〈 0.05). The methyla- tion status of DLC-1 gene was also related to TNM stages (χ^2 = 10.8478, P 〈 0.05). After shortterm following-up, the median survival time was significantly different between HCC patients with positive- and negative methylation of DLC-1 gene (9.45 mo vs 36 mo, P 〈 0.05). CONCLUSION: The aberrant methylation of DLC-1 gene may not only offer an effective method for the early auxiliary diagnosis of invasion and metastasis, but also serve as an new target for HCC therapies.
出处
《世界华人消化杂志》
CAS
北大核心
2008年第11期1237-1240,共4页
World Chinese Journal of Digestology
基金
江苏省南通市科技局课题资助项目
No.ntzl200305~~
关键词
肝细胞癌
转移
甲基化
DLC-1
甲基化特异性PCR
Hepatocellular carcinoma
Metastasis
Methylation
DLC-1
Methylation-specific polymerase chain reaction